• Printer Friendly Version
  • Decrease Text Size Increase Text Size
  • Download as PDF

COVID-19 Vaccination Boosters

Federal officials announced on August 18 that COVID-19 vaccine boosters would begin on September 20 for the general population. Despite this announcement, vaccine boosters are not yet approved by FDA or CDC for administration among the general public. Aspirus Health will not be scheduling patients for vaccine boosters until official authorization is made by these agencies.

Once approved, all indications are that everyone who received either the Moderna or Pfizer vaccine will be recommended to receive a booster about eight months following the final dose of the initial series.

Currently, the CDC has only granted approval for moderately to severely immunocompromised people to receive an additional dose. This includes people who have:

  • Been receiving active cancer treatment for tumors or cancers of the blood.
  • Received an organ transplant and are taking medicine to suppress the immune system.
  • Received a stem cell transplant within the last 2 years or are taking medicine to suppress the immune system.
  • Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome).
  • Advanced or untreated HIV infection.
  • Active treatment with high-dose corticosteroids or other drugs that may suppress your immune response.

People should talk to their health care provider about these medical conditions, and whether getting an additional dose is appropriate for them.

Additional details on boosters will be posted as they become available.